US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

41.95

+0.14880.36%

Post-market: 42.090.1362+0.32%19:30 EDT

Volume:271

Turnover:11.43K

Market Cap:31.47M

PE:- -

High:42.09

Open:42.03

Low:41.95

Close:41.81

52wk High:43.51

52wk Low:29.80

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.31

T/O Rate:0.04%

Dividend:0.14

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live

Guardant Health is Maintained at Buy by BTIG

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS

Guardant Health files automatic mixed securities shelf

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live

Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS

Adaptive Biotechnologies is Maintained at Buy by Guggenheim

Asymchem Laboratories Injects RMB 1.05 Billion into Shanghai Subsidiary

Natera Schedules Second-quarter Results Conference Call

Adaptive Biotechnologies price target raised to $25 from $24 at BTIG

Adaptive Biotechnologies Corp : Morgan Stanley Raises Target Price to $22 from $20

THOMSON REUTERS

Metabolic disorder biotech Vogenx targets $75 million IPO at $11-$13 per share

Natera CFO Michael Burkes Brophy Disposes of USD 1.29 Million in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/HELX/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":41.9538,"timestamp":1788292800000,"preClose":41.805,"halted":0,"volume":271,"hourTrading":{"tag":"盘后","latestPrice":42.09,"preClose":41.9538,"latestTime":"19:30 EDT","volume":7,"amount":293.6766,"timestamp":1788305405745,"change":0.1362,"changeRate":0.003246,"amplitude":0},"delay":0,"changeRate":0.003559382848941547,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Closed","change":0.1488,"latestTime":"09-01 16:00:00 EDT","open":42.03,"high":42.09,"low":41.9538,"amount":11427.167028,"amplitude":0.003258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":41.805,"sharesOutstanding":650000,"nav":42.057,"aum":31542583.03,"dividendRate":0.003387,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":42.09,"preClose":41.9538,"latestTime":"19:30 EDT","volume":7,"amount":293.6766,"timestamp":1788305405745,"change":0.1362,"changeRate":0.003246,"amplitude":0},"volumeRatio":0.313295,"impliedVol":0.0655,"impliedVolPercentile":0.0635},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.313295,"shares":750000,"dividePrice":0.1421,"high":42.09,"amplitude":0.003258,"preClose":41.805,"low":41.9538,"week52Low":29.8,"pbRate":"--","week52High":43.5089,"institutionHeld":0,"latestPrice":41.9538,"eps":0,"divideRate":0.003387,"volume":271,"delay":0,"ttmEps":0,"open":42.03,"prevYearClose":36.3062,"prevWeekClose":42.0768,"prevMonthClose":41.805,"prevQuarterClose":39.9651,"fiveDayClose":43.3608,"twentyDayClose":39.3001,"sixtyDayClose":35.7434},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655912361","title":"RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2655912361","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655912361?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:16","pubTimestamp":1785503760,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $191.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","GDOC","EKG","HELX","LU0320765992.SGD","BK4551","BK4585","FFOX","GH","LFSC","PTH","GNMX","GNOM","BK4535","LU0889565916.HKD","BK4196","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655350944","title":"Guardant Health is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2655350944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655350944?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:39","pubTimestamp":1785494340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","FFOX","EKG","HELX","GNMX","BK4535","LFSC","GDOC","GNOM","LU0109394709.USD","LU0889565916.HKD","BK4551","LU0320765992.SGD","BK4196","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655353488","title":"Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655353488","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655353488?lang=en_us&edition=fundamental","pubTime":"2026-07-31 15:36","pubTimestamp":1785483375,"startTime":"0","endTime":"0","summary":"Guardant Health Inc reports results for the quarter ended June 30 - Earnings SummaryGuardant Health IncGH.OQreported a quarterly adjusted loss of 42 cents per share for the quarter ended June 30, high","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","GDOC","BK4588","EKG","BK4585","BK4535","GH","PTH","FFOX","GNMX","GNOM","LFSC","LU0109394709.USD","LU0320765992.SGD","HELX","BK4551","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655330669","title":"Guardant Health Inc : RBC Raises Target Price to $200 from $185","url":"https://stock-news.laohu8.com/highlight/detail?id=2655330669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655330669?lang=en_us&edition=fundamental","pubTime":"2026-07-31 14:39","pubTimestamp":1785479966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X1FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","GNMX","GNOM","BK4196","PTH","EKG","FFOX","GH","HELX","LFSC","BK4535","GDOC","BK4588","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655381477","title":"Guardant Health files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2655381477","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655381477?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:35","pubTimestamp":1785447326,"startTime":"0","endTime":"0","summary":"17:32 EDT Guardant Health (GH) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-files-automatic-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","LU0889565916.HKD","GNMX","BK4585","PTH","BK4196","HELX","BK4588","LU0109394709.USD","GDOC","GH","EKG","FFOX","GNOM","LFSC","LU0320765992.SGD","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655838199","title":"Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655838199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655838199?lang=en_us&edition=fundamental","pubTime":"2026-07-31 05:31","pubTimestamp":1785447087,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W2KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","GDOC","FFOX","LU0109394709.USD","BK4585","GNOM","PTH","BK4196","GNMX","EKG","LU0320765992.SGD","BK4551","LU0889565916.HKD","GH","LFSC","BK4588","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655386195","title":"Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2655386195","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655386195?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:25","pubTimestamp":1785443116,"startTime":"0","endTime":"0","summary":"Guardant Health  reported Thursday Q2 adjusted loss of $0.42 per diluted share, compared with a loss of $0.44 a year earlier.Analysts polled by FactSet expected loss of $0.39.Revenue for the quarter ended June 30 was $335.0 million, up from $232.1 million a year ago.Analysts expected $314.2 million.The company now expects full year 2026 revenue between $1.34 billion and $1.36 billion, up from $1.30 billion to $1.32 billion earlier. Analysts expect $1.31 billion.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4535","GNMX","BK4585","GH","LU0889565916.HKD","LU0109394709.USD","GNOM","BK4588","BK4551","GDOC","LFSC","PTH","HELX","FFOX","EKG","LU0320765992.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385718","title":"Veracyte Q2 Revenue Rises on Decipher and Afirma Test Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385718","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385718?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:23","pubTimestamp":1785442985,"startTime":"0","endTime":"0","summary":"Veracyte Q2 revenue rises on Decipher and Afirma test salesOverviewCancer diagnostics firm's Q2 revenue rose 15% yr/yr, beating analyst expectationsAdjusted EPS for Q2 increased from prior year, suppo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121","VCYT","REPL","LU0012050646.USD","BK4196","NEO","HELX","LU0106261612.USD","FBT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655938517","title":"Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay","url":"https://stock-news.laohu8.com/highlight/detail?id=2655938517","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655938517?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:18","pubTimestamp":1785442707,"startTime":"0","endTime":"0","summary":"Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delayOverviewGenetic testing firm's Q2 revenue rose 20% sequentiallyCompany posted a GAAP net loss and non-GAAP loss ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0742534661.SGD","LU1059921491.USD","LH","LU0251131958.USD","BK4550","LU0106261612.USD","LU0012050646.USD","BK4588","LU0006061336.USD","ADPT","FLGT","BK4196","HELX","BK4585","LU2237438978.USD","BK4121","FBT","LU0251142724.SGD","LU0048573561.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383003","title":"CareDx Q2 Revenue Beats Estimates; Outlook Lifted","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383003","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383003?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:10","pubTimestamp":1785442216,"startTime":"0","endTime":"0","summary":"CareDx Q2 revenue beats estimates; outlook liftedOverviewPrecision medicine diagnostics firm's Q2 revenue rose 52% yr/yr, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W1H9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006061336.USD","NEO","LU1059921491.USD","BK4588","LU0012050646.USD","BK4196","BK4139","LU0251131958.USD","BK4585","FBT","LH","CDNA","LU0106261612.USD","BK4550","HELX","BK4121","LU0048573561.USD","LU0742534661.SGD","ADPT","LU2237438978.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655438321","title":"Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655438321","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655438321?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:06","pubTimestamp":1785441998,"startTime":"0","endTime":"0","summary":"Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 4.55 percent increase over losses of $(0.44) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60820598/guardant-health-q2-adj-eps-0-42-misses-0-41-estimate-sales-334-978m-beat-314-226m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4551","GH","GNMX","GNOM","LFSC","EKG","BK4588","GDOC","FFOX","BK4196","BK4535","HELX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383221","title":"Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383221","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383221?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:06","pubTimestamp":1785441961,"startTime":"0","endTime":"0","summary":"BRIEF-Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41Jul 30  - Guardant Health Q2 revenue USD 335 million vs. IBES estimate USD 314.2 million.Q2 EPS USD -0.9Q2 adjusted net income USD -56.2 million vs. IBES estimate USD -54.3 millionQ2 adjusted EBITDA USD -55.9 million vs. IBES estimate USD -50.3 millionoutlook FY revenue USD 1,340-1,360 million vs. IBES estimate USD 1,314 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXKDV64K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GDOC","LU0109394709.USD","LU0889565916.HKD","BK4535","FFOX","LFSC","EKG","GH","BK4588","HELX","BK4551","BK4585","GNOM","PTH","GNMX","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655538687","title":"Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2655538687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655538687?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:05","pubTimestamp":1785441902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXKDV64K:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","BK4588","GDOC","BK4196","LU0109394709.USD","LU0889565916.HKD","GH","BK4551","GNOM","GNMX","LU0320765992.SGD","HELX","BK4535","EKG","PTH","LFSC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655742803","title":"Adaptive Biotechnologies is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2655742803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655742803?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:59","pubTimestamp":1785419940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADPT/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120368588","title":"Asymchem Laboratories Injects RMB 1.05 Billion into Shanghai Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=1120368588","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120368588?lang=en_us&edition=fundamental","pubTime":"2026-07-30 21:56","pubTimestamp":1785419776,"startTime":"0","endTime":"0","summary":"Asymchem Laboratories (06821) announced on July 30, 2026, that it has entered into a capital increase agreement with its target company, Shanghai Asymchem Biotechnology Development Co., Ltd., along...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","LU1328615791.USD","BK0132","002821","BK0239","BK1191","06821","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655836872","title":"Natera Schedules Second-quarter Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836872","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836872?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:01","pubTimestamp":1785412902,"startTime":"0","endTime":"0","summary":"Natera schedules second-quarter results conference callNatera schedules second-quarter 2026 results release for Aug. 6, 2026, following the market close.Conference call, webcast set for Aug. 6, 2026 a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLtKpZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","NTRA","LU2065171311.SGD","LU0053671581.USD","BK4139","LU2065731478.USD","LU2264538146.SGD","LU2065170008.USD","LU1064131342.USD","LU0106261612.USD","LU0963586101.USD","HELX","LU2065171402.SGD","LU0345770993.USD","LU1988902786.USD","GNOM","LU2324357040.USD","LU0012050646.USD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655874391","title":"Adaptive Biotechnologies price target raised to $25 from $24 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2655874391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655874391?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:40","pubTimestamp":1785411637,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $25 from $24 and keeps a Buy rating on the shares. The company delivered ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adaptive-biotechnologies-price-target-raised-to-25-from-24-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adaptive-biotechnologies-price-target-raised-to-25-from-24-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655876284","title":"Adaptive Biotechnologies Corp : Morgan Stanley Raises Target Price to $22 from $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2655876284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655876284?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:59","pubTimestamp":1785409169,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W1GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","ADPT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140094349","title":"Metabolic disorder biotech Vogenx targets $75 million IPO at $11-$13 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=1140094349","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140094349?lang=en_us&edition=fundamental","pubTime":"2026-07-30 16:23","pubTimestamp":1785399812,"startTime":"0","endTime":"0","summary":"Metabolic disorder-focused biotechnology company Vogenx (VOGX.US) announced the terms of its initial public offering on Wednesday. The company, which is currently advancing a Phase 2b clinical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UUP","WDNA","IPOS","HELX","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655846515","title":"Natera CFO Michael Burkes Brophy Disposes of USD 1.29 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655846515","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655846515?lang=en_us&edition=fundamental","pubTime":"2026-07-30 09:35","pubTimestamp":1785375339,"startTime":"0","endTime":"0","summary":"Natera CFO Michael Burkes Brophy disposes of USD 1.29 million in common sharesNatera CFO Michael Burkes Brophy sold 5,064 common shares on July 27-29, 2026.Sales prices ranged from USD 249.38 to USD 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL5TDhd8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera CFO Michael Burkes Brophy Disposes of USD 1.29 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU2264538146.SGD","LU2065171402.SGD","HELX","LU0345770993.USD","LU0053671581.USD","LU0963586101.USD","LU0106261612.USD","LU0345770308.USD","NTRA","LU1064131342.USD","LU1988902786.USD","BK4139","GNOM","LU2065169927.USD","LU2065170008.USD","LU2065731478.USD","LU0012050646.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}